Polypill, which is a combination of drugs for heart disease, is being seen as an important pill which can save thousands of lives.
According to leaders of the study, the pill has a "considerable potential to improve global health" and are thus favouring it to be licensed across the world.
The cheap polypill will replace cocktail of drugs for the heart disease. Polypill which combines two blood pressure drugs, statins and aspirin, was found to lower cholesterol and hypertension.
Scientists said over 3,000 patients, many in the UK, were taken up for the trial and the results offered hope to all heart patients.
Ruth Webster of the George Institute for Global Health in Sydney which led the research, said, "Most patients either don't start or don't continue taking all the medications they need, which can lead to untimely death or further cardiovascular events."
The research presented before the World Heart Federation said that people were more likely to remember to take a single, fixed-dose pill instead of four different medicines for cardiovascular disease.
Cardiovascular disease is the world's biggest killer and 180,000 in Britain die from it every year.
Professor Salim Yusuf of the World Heart Federation, said, "These results emphasise the importance of the polypill as a foundation for a global strategy on cardiovascular disease prevention. It will improve patient access to essential medications at an affordable cost."
According to researchers, a polypill will be available for Ģ1 each within two years and it will be cheaper compared to taking multiple drugs for the problem.